Grace Therapeutics Inc (GRCE)

Finanzdaten der Grace Therapeutics Inc-Aktie (GRCE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	65.95%0.70	0.42	0.46	0.57	0.96
Research and Development	65.95%0.70	0.42	0.46	0.57	0.96
Operating Income/Loss	428.80%-15.92	-3.01	-2.45	-2.53	-3.09
Nonoperating Income/Loss	3.79%0.13	0.13	0.13	1.59	-0.27
Income/Loss From Continuing Operations Before Tax	448.64%-15.79	-2.88	-2.32	-0.94	-3.36
Income Tax Expense/Benefit	100.00%-	-1.70	-	-	-
	1,240%-15.79	-1.18	-2.32	-0.94	-3.36
Attributable To Parent	1,240%-15.79	-1.18	-2.32	-0.94	-3.36
Basic Average Shares	17.27	-	16.93	15.92	15.92
Diluted Average Shares	17.27	-	16.93	15.92	15.92
Basic Earnings Per Share	-0.91	-	-0.14	-0.06	-0.21
Diluted Earnings Per Share	-0.91	-	-0.14	-0.06	-0.21